Researchers are testing a fully human monoclonal antibody that inhibits the activity of insulin-like growth factors (IGF-1 and IGF-2) and appears to reduce pancreatic cancer cells in early testing, according to a new article.
Full article >>
Wednesday, April 15, 2009
Experimental Insulin-like Growth Factor Receptor Inhibitor Reduced Pancreatic Cancer Growth
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment